Package 68682-307-05

Brand: pyridostigmine bromide

Generic: pyridostigmine bromide
NDC Package

Package Facts

Identity

Package NDC 68682-307-05
Digits Only 6868230705
Product NDC 68682-307
Product ID 68682-307_dea0cb1f-7ec8-4f54-968f-8f095fa8ac95
Description

473 mL in 1 BOTTLE (68682-307-05)

Marketing

Marketing Status
Marketed Since 2019-07-01
Brand pyridostigmine bromide
Generic pyridostigmine bromide
Sample Package No

Linked Drug Pages (1)

pyridostigmine bromide ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "dea0cb1f-7ec8-4f54-968f-8f095fa8ac95", "openfda": {"unii": ["KVI301NA53"], "rxcui": ["903843"], "spl_set_id": ["970a0191-693c-480b-aeff-9f8956936159"], "manufacturer_name": ["Oceanside Pharmaceuticals"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "473 mL in 1 BOTTLE (68682-307-05)", "package_ndc": "68682-307-05", "marketing_start_date": "20190701"}], "brand_name": "pyridostigmine bromide", "product_id": "68682-307_dea0cb1f-7ec8-4f54-968f-8f095fa8ac95", "dosage_form": "SOLUTION", "pharm_class": ["Cholinesterase Inhibitor [EPC]", "Cholinesterase Inhibitors [MoA]"], "product_ndc": "68682-307", "generic_name": "pyridostigmine bromide", "labeler_name": "Oceanside Pharmaceuticals", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "pyridostigmine bromide", "active_ingredients": [{"name": "PYRIDOSTIGMINE BROMIDE", "strength": "60 mg/5mL"}], "application_number": "NDA015193", "marketing_category": "NDA AUTHORIZED GENERIC", "marketing_start_date": "20190701", "listing_expiration_date": "20261231"}